Skip to content

Effects of Liuzijue Qigong combined with Repetitive Transcranial Magnetic Stimulation on Post-Stroke Dysphagia: A Single-Center, Single-Blind, Randomized Controlled Trial.

Effects of Liuzijue Qigong combined with Repetitive Transcranial Magnetic Stimulation on Post-Stroke Dysphagia: A Single-Center, Single-Blind, Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600131546
Enrollment
Unknown
Registered
2026-09-03
Start date
2023-12-23
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Stroke Dysphagia

Interventions

Group C:“Liuzijue”Qigong breathing training+Conventional therapy
Group D:“Liuzijue”Qigong breathing training+rTMS+Conventional therapy
Group B:Repetitive transcranial magnetic stimulation(rTMS)+ Conventional therapy

Sponsors

Peoples Hospital of Longhua Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. diagnosis of subacute, first-ever unilateral ischemic or hemorrhagic stroke involving the supratentorial region (time since onset = 3 months), verified by computed tomography or magnetic resonance imaging. 2. age between 35 and 70 years; 3. A score of more than 3 on the Eating Assessment Tool-10 (EAT-10); 4. preserved consciousness, stable psychological status, and a Mini-Mental State Examination score above 24; 5. presence of swallowing impairment confirmed by videofluoroscopic swallowing study (VFSS), including delayed initiation of swallowing, pharyngeal residue, and inadequate laryngeal closure.

Exclusion criteria

Exclusion criteria: 1. pre-existing dysphagia secondary to other neurological disorders, including but not limited to traumatic brain injury, conditions such as Alzheimer’s disease, Parkinson’s disease, motor neuron disease, or encephalitis; 2. documented history of refractory epilepsy; 3. intracranial or cardiac metallic implants; 4. hemodynamic or clinical instability, or being in the acute stage of stroke; 5. severe aphasia and/or prominent psychiatric disturbances or marked cognitive deficits; 6. infratentorial (subtentorial) stroke.

Design outcomes

Primary

MeasureTime frame
Standardized Swallowing Assessment (SSA);

Secondary

MeasureTime frame
Functional Oral Intake Scale(FOIS);Water Swallow Test (WST);albumin;

Countries

China

Contacts

Public ContactShafei Ouyang

Peoples Hospital of Longhua Shenzhen

363731058@qq.com+86 755 27741585

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026